Towards a more rational regulation of the development of new medicines. Report of a European workshop held in Sestri Levante, Italy, September 28-30, 1976
- PMID: 852499
Towards a more rational regulation of the development of new medicines. Report of a European workshop held in Sestri Levante, Italy, September 28-30, 1976
Similar articles
-
Pharmacological and safety aspects of existing requirements and regulations when introducing a new drug.Arzneimittelforschung. 1974 Apr;24(4):504-8. Arzneimittelforschung. 1974. PMID: 4408328 No abstract available.
-
Drug metabolism: an industrial research view of the future.Drug Metab Rev. 1979;10(2):315-9. doi: 10.3109/03602537908997477. Drug Metab Rev. 1979. PMID: 551917 No abstract available.
-
Developing a European framework for research on children's medicines: an examination of the proposed EU regulation on medicinal products for paediatric use.Pediatr Nephrol. 2005 Nov;20(11):1537-40. doi: 10.1007/s00467-005-2103-6. Epub 2005 Sep 16. Pediatr Nephrol. 2005. PMID: 16167134 No abstract available.
-
AIDS drugs & the pharmaceutical industry: a need for reform.Am J Law Med. 1991;17(4):363-410. Am J Law Med. 1991. PMID: 1812767 Review.
-
[Drug evaluation: new requirements and perspectives].Recenti Prog Med. 2006 Nov;97(11):618-25. Recenti Prog Med. 2006. PMID: 17252718 Review. Italian.
Cited by
-
Once is not enough.Eur J Clin Pharmacol. 1977;11(5):323-4. doi: 10.1007/BF00566527. Eur J Clin Pharmacol. 1977. PMID: 880970 No abstract available.
-
Uses and limitations of primates in the evaluation of drug efficacy and safety.J R Soc Med. 1978 Sep;71(9):691-2. doi: 10.1177/014107687807100914. J R Soc Med. 1978. PMID: 712749 Free PMC article. No abstract available.
-
Constraints of drug regulation on the development of new drugs.Arch Toxicol. 1979 Oct;43(1):9-17. doi: 10.1007/BF00695869. Arch Toxicol. 1979. PMID: 533368
-
[Trend reversal in drug research].Naturwissenschaften. 1977 Dec;64(12):601-5. doi: 10.1007/BF00440091. Naturwissenschaften. 1977. PMID: 593414 German.
-
Toxicological barriers to providing better drugs.Arch Toxicol. 1979 Oct;43(1):27-33. doi: 10.1007/BF00695871. Arch Toxicol. 1979. PMID: 533359